These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27837170)

  • 21. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.
    Ji G; Neugebauer V
    J Neurophysiol; 2007 Jun; 97(6):3893-904. PubMed ID: 17392412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin interactions with oxytocin in the control of female sexual behavior.
    Pedersen CA; Boccia ML
    Neuroscience; 2006; 139(3):843-51. PubMed ID: 16488546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    Stam WB; Van der Graaf PH; Saxena PR
    Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
    Chen YL; Shepherd C; Spinelli W; Lai FM
    Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxytocin-induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V1A receptors and not oxytocin receptors.
    Gupta J; Russell R; Wayman C; Hurley D; Jackson V
    Br J Pharmacol; 2008 Sep; 155(1):118-26. PubMed ID: 18552879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.
    Salomé N; Stemmelin J; Cohen C; Griebel G
    Psychopharmacology (Berl); 2006 Aug; 187(2):237-44. PubMed ID: 16779555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
    Serradeil-Le Gal C; Herbert JM; Delisee C; Schaeffer P; Raufaste D; Garcia C; Dol F; Marty E; Maffrand JP; Le Fur G
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
    Beyer CE; Dwyer JM; Platt BJ; Neal S; Luo B; Ling HP; Lin Q; Mark RJ; Rosenzweig-Lipson S; Schechter LE
    Psychopharmacology (Berl); 2010 May; 209(4):303-11. PubMed ID: 20224888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.
    Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G
    Biochem Biophys Res Commun; 1994 Feb; 199(1):353-60. PubMed ID: 8123034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.
    Hicks C; Ramos L; Reekie T; Misagh GH; Narlawar R; Kassiou M; McGregor IS
    Br J Pharmacol; 2014 Jun; 171(11):2868-87. PubMed ID: 24641248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT
    Ji G; Zhang W; Mahimainathan L; Narasimhan M; Kiritoshi T; Fan X; Wang J; Green TA; Neugebauer V
    J Neurosci; 2017 Feb; 37(6):1378-1393. PubMed ID: 28011743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin V1a, but not V1b, receptors within the PVN of lactating rats mediate maternal care and anxiety-related behaviour.
    Bayerl DS; Hönig JN; Bosch OJ
    Behav Brain Res; 2016 May; 305():18-22. PubMed ID: 26909846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V
    García-Boll E; Martínez-Lorenzana G; Condés-Lara M; González-Hernández A
    Neuropharmacology; 2018 Feb; 129():109-117. PubMed ID: 29169960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain.
    Li W; Neugebauer V
    Pain; 2004 Jul; 110(1-2):112-22. PubMed ID: 15275758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytocin and vasopressin enhance synaptic transmission in the hypoglossal motor nucleus of young rats by acting on distinct receptor types.
    Wrobel LJ; Reymond-Marron I; Dupré A; Raggenbass M
    Neuroscience; 2010 Feb; 165(3):723-35. PubMed ID: 19896520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala.
    Huber D; Veinante P; Stoop R
    Science; 2005 Apr; 308(5719):245-8. PubMed ID: 15821089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of FE 201874, the first selective high affinity rat V1A vasopressin receptor agonist.
    Marir R; Virsolvy A; Wisniewski K; Mion J; Haddou D; Galibert E; Meraihi Z; Desarménien MG; Guillon G
    Br J Pharmacol; 2013 Sep; 170(2):278-92. PubMed ID: 23725319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Phoenixin-14 on anxiolytic-like behavior in mice.
    Jiang JH; He Z; Peng YL; Jin WD; Mu J; Xue HX; Wang Z; Chang M; Wang R
    Behav Brain Res; 2015 Jun; 286():39-48. PubMed ID: 25687846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of peripheral V2 receptor vasopressin signaling fails to correct behavioral changes in Brattleboro rats.
    Balázsfi D; Pintér O; Klausz B; Kovács KB; Fodor A; Török B; Engelmann M; Zelena D
    Psychoneuroendocrinology; 2015 Jan; 51():11-23. PubMed ID: 25278460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors.
    Song Z; McCann KE; McNeill JK; Larkin TE; Huhman KL; Albers HE
    Psychoneuroendocrinology; 2014 Dec; 50():14-9. PubMed ID: 25173438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.